Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs151132 | chr17:3271948 | T/G | 0.000426 | 171 | 18.2 | 25 | 27.2 | KM Plot |
PCPG | rs151185675 | chr7:105167992 | TC/T | 6.69E-5 | 174 | 20.28 | 30.45 | 2.28 | KM Plot |
PCPG | rs151187 | chr17:3251078 | A/G | 0.000207 | 173 | 18.1 | 25.87 | 26.88 | KM Plot |
PCPG | rs1512085 | chr2:107246133 | A/G | 0.000261 | 175 | 26.57 | 23.53 | 25.87 | KM Plot |
PCPG | rs1512086 | chr2:107246425 | T/C | 0.000213 | 178 | 26.57 | 23.53 | 25.87 | KM Plot |
PCPG | rs1512087 | chr2:107250055 | G/C | 0.000212 | 178 | 26.57 | 21.95 | 25.87 | KM Plot |
PCPG | rs151235380 | chr7:105162638 | G/C | 5.12E-5 | 178 | 20.2 | 29.43 | 2.28 | KM Plot |
PCPG | rs1516581 | chr3:80593229 | T/C | 0.000124 | 177 | 19.87 | 24.03 | 27.4 | KM Plot |
PCPG | rs1516582 | chr3:80585039 | T/A | 6.33E-5 | 177 | 19.53 | 24.53 | 27.4 | KM Plot |
PCPG | rs1516585 | chr3:80604703 | A/G | 5.95E-5 | 178 | 27.2 | 23.53 | 19.53 | KM Plot |
PCPG | rs1534008 | chr7:156259583 | C/T | 3.79E-5 | 175 | 25.7 | 19.42 | 2.93 | KM Plot |
PCPG | rs1535278 | chr6:26481317 | C/T | 6.66E-7 | 177 | 10.68 | 35.32 | 24.5 | KM Plot |
PCPG | rs1536 | chr14:74524529 | A/G | 0.000221 | 175 | 25.4 | 27.43 | 10.43 | KM Plot |
PCPG | rs1544808 | chr16:71612671 | G/A | 9.96E-6 | 175 | 23.83 | 30.93 | 14.5 | KM Plot |
PCPG | rs1546318 | chr4:78949372 | G/T | 0 | 173 | 2.93 | 25.87 | 25.4 | KM Plot |